WELL 📈 Welltower - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US95040Q1040
WELL: Seniors Housing, Post-Acute Communities, Outpatient Medical Properties
Welltower Inc., a prominent real estate investment trust and S&P 500 company, is at the forefront of revolutionizing healthcare infrastructure. Headquartered in Toledo, Ohio, the company collaborates with top-tier seniors housing operators, post-acute providers, and health systems to finance the development of cutting-edge care delivery models. By doing so, Welltower aims to enhance the overall healthcare experience and promote wellness. The company's strategic investments are focused on creating innovative, patient-centric environments that cater to the evolving needs of the healthcare industry.
Welltower's diverse portfolio comprises interests in properties located in major, high-growth markets across the United States, Canada, and the United Kingdom. The company's assets include a mix of seniors housing and post-acute communities, as well as outpatient medical properties. This strategic diversification enables Welltower to capitalize on emerging trends and opportunities in the healthcare sector, while mitigating potential risks. With a strong presence in key markets, the company is well-positioned to drive growth and expansion in the healthcare real estate space.
As a health care REIT, Welltower is classified under the GICS Sub Industry category, specializing in the development and management of healthcare-related properties. The company's common stock is traded on the New York Stock Exchange under the ticker symbol WELL, with the ISIN code US95040Q1040. For more information on Welltower's business operations, investments, and mission, visit their official website at https://www.welltower.com. With its commitment to transforming healthcare infrastructure and improving patient outcomes, Welltower is an attractive option for investors seeking exposure to the healthcare real estate sector.
Additional Sources for WELL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WELL Stock Overview
Market Cap in USD | 80,402m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2001-01-02 |
WELL Stock Ratings
Growth 5y | 66.3% |
Fundamental | 20.8% |
Dividend | 36.4% |
Rel. Strength Industry | 1144 |
Analysts | 3.95/5 |
Fair Price Momentum | 132.93 USD |
Fair Price DCF | 67.27 USD |
WELL Dividends
Dividend Yield 12m | 2.05% |
Yield on Cost 5y | 3.77% |
Annual Growth 5y | -6.85% |
Payout Consistency | 97.5% |
WELL Growth Ratios
Growth Correlation 3m | 36.5% |
Growth Correlation 12m | 96.6% |
Growth Correlation 5y | 79.9% |
CAGR 5y | 12.91% |
CAGR/Mean DD 5y | 0.85 |
Sharpe Ratio 12m | 1.75 |
Alpha | 10.75 |
Beta | 1.24 |
Volatility | 23.05% |
Current Volume | 11368.6k |
Average Volume 20d | 3557.1k |
As of December 21, 2024, the stock is trading at USD 124.64 with a total of 11,368,600 shares traded.
Over the past week, the price has changed by -3.63%, over one month by -10.42%, over three months by -0.80% and over the past year by +40.33%.
Neither. Based on ValueRay Fundamental Analyses, Welltower is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WELL as of December 2024 is 132.93. This means that WELL is currently overvalued and has a potential downside of 6.65%.
Welltower has received a consensus analysts rating of 3.95. Therefor, it is recommend to buy WELL.
- Strong Buy: 7
- Buy: 5
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, WELL Welltower will be worth about 147.2 in December 2025. The stock is currently trading at 124.64. This means that the stock has a potential upside of +18.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 141.7 | 13.7% |
Analysts Target Price | 89.3 | -28.3% |
ValueRay Target Price | 147.2 | 18.1% |